Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Evolution; International Journal of Organic Evolution
|
October 2, 2002
Recent and ancient asexuality in Timema walkingsticks
Jennifer H Law, Bernard J Crespi
Molecular Ecology
|
July 30, 2002
The evolution of geographic parthenogenesis in Timema walking-sticks
Jennifer H Law, Bernard J Crespi
Breast Cancer Research : BCR
|
February 8, 2012
Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells
Kaiji Hu, Jennifer H Law, Abbas Fotovati, et al.
JTO Clinical and Research Reports
|
August 20, 2025
Impact of the COVID-19 Pandemic on Diagnosis and Multidisciplinary Treatment of NSCLC in Ontario, Canada
Kirstin Perdrizet, Lisa W Le, Anthea Lau, et al.
Anaerobe
|
February 12, 2017
Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods
Christine J Hastey, Suzanne E Dale, Julia Nary, et al.
Current Oncology (Toronto, Ont.)
|
August 27, 2021
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer-A Cost-Efficient Strategy in a Public Healthcare System
Maisam Makarem, Doreen A Ezeife, Adam C Smith, et al.
Translational Oncogenomics
|
May 7, 2013
Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK)
Nancy Dos Santos, Golareh Habibi, Michelle Wang, et al.
Breast Cancer Research : BCR
|
October 18, 2008
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi, Samuel Leung, Jennifer H Law, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 31, 2026
Factors Associated With Long-Term Survivors With Epidermal Growth Factor Receptor Positive Non-Small Cell Lung Cancer Treated With First or Second-Generation Tyrosine Kinase Inhibitors: A Canadian Multi-Center Cohort
Heather Halperin, Amanda J W Gibson, Ali Hussein, et al.
Plos One
|
September 17, 2010
Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability
Jennifer H Law, Yvonne Li, Karen To, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Evolution; International Journal of Organic Evolution
|
October 2, 2002
Recent and ancient asexuality in Timema walkingsticks
Jennifer H Law, Bernard J Crespi
Molecular Ecology
|
July 30, 2002
The evolution of geographic parthenogenesis in Timema walking-sticks
Jennifer H Law, Bernard J Crespi
Breast Cancer Research : BCR
|
February 8, 2012
Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells
Kaiji Hu, Jennifer H Law, Abbas Fotovati, et al.
JTO Clinical and Research Reports
|
August 20, 2025
Impact of the COVID-19 Pandemic on Diagnosis and Multidisciplinary Treatment of NSCLC in Ontario, Canada
Kirstin Perdrizet, Lisa W Le, Anthea Lau, et al.
Anaerobe
|
February 12, 2017
Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods
Christine J Hastey, Suzanne E Dale, Julia Nary, et al.
Current Oncology (Toronto, Ont.)
|
August 27, 2021
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer-A Cost-Efficient Strategy in a Public Healthcare System
Maisam Makarem, Doreen A Ezeife, Adam C Smith, et al.
Translational Oncogenomics
|
May 7, 2013
Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK)
Nancy Dos Santos, Golareh Habibi, Michelle Wang, et al.
Breast Cancer Research : BCR
|
October 18, 2008
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi, Samuel Leung, Jennifer H Law, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 31, 2026
Factors Associated With Long-Term Survivors With Epidermal Growth Factor Receptor Positive Non-Small Cell Lung Cancer Treated With First or Second-Generation Tyrosine Kinase Inhibitors: A Canadian Multi-Center Cohort
Heather Halperin, Amanda J W Gibson, Ali Hussein, et al.
Plos One
|
September 17, 2010
Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability
Jennifer H Law, Yvonne Li, Karen To, et al.
Page
of 3